GC
Gratus Capital Portfolio holdings
AUM
$2.48B
1-Year Return
32.66%
This Quarter Return
+18.72%
1 Year Return
+32.66%
3 Year Return
+50.91%
5 Year Return
+137.89%
10 Year Return
–
AUM
$587M
AUM Growth
+$79.7M
(+16%)
Cap. Flow
-$3.32M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
24.5%
Holding
174
New
14
Increased
35
Reduced
81
Closed
15
Top Buys
| 1 |
Schwab US Large- Cap ETF
SCHX
|
$16.2M |
| 2 |
iShares AAA-A Rated Corporate Bond ETF
QLTA
|
$8.66M |
| 3 |
AstraZeneca
AZN
|
$7.33M |
| 4 |
Hasbro
HAS
|
$7.26M |
| 5 |
CME Group
CME
|
$6.98M |
Top Sells
| 1 |
Schwab US Large-Cap Value ETF
SCHV
|
$18.1M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
$7.39M |
| 3 |
BP
BP
|
$6.86M |
| 4 |
Weyerhaeuser
WY
|
$6.57M |
| 5 |
Brookfield
BN
|
$6.18M |
Sector Composition
| 1 | Technology | 16.65% |
| 2 | Healthcare | 13.01% |
| 3 | Financials | 10.6% |
| 4 | Industrials | 9.03% |
| 5 | Consumer Discretionary | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAVN
101
DELISTED
Raven Industries Inc
RAVN
| $1.05M | 0.18% |
48,707
-2,500
| -5% | -$53.8K |
|
102
Northrop Grumman
NOC
$82.8B
| $992K | 0.17% |
3,228
| – | – |
|
103
Invesco FTSE RAFI US 1000 ETF
PRF
$8.11B
| $989K | 0.17% |
45,650
-13,755
| -23% | -$298K |
|
104
Franco-Nevada
FNV
$36.6B
| $977K | 0.16% |
7,000
+3,500
| +100% | +$489K |
|
105
Northeast Bank
NBN
$935M
| $880K | 0.15% |
50,160
-25,000
| -33% | -$439K |
|
106
Fastenal
FAST
$57.3B
| $847K | 0.14% |
39,560
-10,500
| -21% | -$225K |
|
107
Eli Lilly
LLY
$667B
| $824K | 0.14% |
5,020
+13
| +0.3% | +$2.13K |
|
108
Novartis
NVS
$249B
| $806K | 0.14% |
9,234
-197
| -2% | -$17.2K |
|
109
Vanguard S&P 500 ETF
VOO
$729B
| $794K | 0.13% |
2,801
-3,600
| -56% | -$1.02M |
|
110
US Bancorp
USB
$76.5B
| $759K | 0.13% |
20,627
-21,035
| -50% | -$774K |
|
111
Hershey
HSY
$37.6B
| $739K | 0.12% |
5,705
| – | – |
|
112
American Water Works
AWK
$27.5B
| $611K | 0.1% |
4,750
| – | – |
|
113
Merck
MRK
$210B
| $580K | 0.1% |
7,858
-70
| -0.9% | -$5.17K |
|
114
Bristol-Myers Squibb
BMY
$95.5B
| $529K | 0.09% |
9,004
+921
| +11% | +$54.1K |
|
115
Invesco S&P 500 Equal Weight ETF
RSP
$73.9B
| $525K | 0.09% |
5,158
| – | – |
|
|
116
Schwab US Large-Cap Value ETF
SCHV
$13.2B
| $524K | 0.09% |
31,380
-1,081,353
| -97% | -$18.1M |
|
117
Truist Financial
TFC
$60.6B
| $501K | 0.08% |
13,343
-1,634
| -11% | -$61.4K |
|
118
Mondelez International
MDLZ
$79.1B
| $444K | 0.07% |
8,679
| – | – |
|
119
Altria Group
MO
$112B
| $440K | 0.07% |
11,222
+2
| +0% | +$78 |
|
120
PNC Financial Services
PNC
$81.5B
| $433K | 0.07% |
4,112
| – | – |
|
121
Bank of America
BAC
$375B
| $408K | 0.07% |
17,184
-150
| -0.9% | -$3.56K |
|
122
iShares Russell 1000 Value ETF
IWD
$63.6B
| $402K | 0.07% |
3,569
-302
| -8% | -$34K |
|
123
Philip Morris
PM
$249B
| $397K | 0.07% |
5,671
+2
| +0% | +$140 |
|
124
GSK
GSK
$79.6B
| $368K | 0.06% |
7,227
+61
| +0.9% | +$3.11K |
|
|
125
Weyerhaeuser
WY
$18.4B
| $367K | 0.06% |
16,324
-292,265
| -95% | -$6.57M |
|